Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Vandenberghe

Showing results (61-70 of 108) with videos related to

Pageof 11
Sort By:
Frontiers in Neurology|May 9, 2024
Testing of symmetric biphasic stimulation in Vim-DBS ET patients: a randomized-controlled pilot studyAlexandra Boogers, Jana Peeters, Tine Van Bogaert, et al.
Research in Immunology|March 1, 1995
CD80 (B7-1) and CD86 (B7-2): potential targets for immunotherapy?S W van Gool, S Barcy, S Devos, et al.
British Journal of Haematology|February 1, 1996
Feasibility of peripheral blood progenitor cell harvest and transplantation in patients with poor-risk myelodysplastic syndromesH Demuynck, M Delforge, G E Verhoef, et al.
Journal of Clinical Microbiology|September 17, 1999
Autopsy-controlled prospective evaluation of serial screening for circulating galactomannan by a sandwich enzyme-linked immunosorbent assay for hematological patients at risk for invasive AspergillosisJ Maertens, J Verhaegen, H Demuynck, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 19, 2016
EBV-Positive and EBV-Negative Posttransplant Diffuse Large B Cell Lymphomas Have Distinct Genomic and Transcriptomic FeaturesJ Finalet Ferreiro, J Morscio, D Dierickx, et al.
Cancer Genetics and Cytogenetics|July 15, 1995
Therapy-related acute myeloid leukemia with t(8;16)(p11;p13) following anthracycline-based therapy for nonmetastatic osteosarcomaH Demuynck, G E Verhoef, P Zachée, et al.
Leukemia|February 16, 2007
A new disease categorization of low-grade myelodysplastic syndromes based on the expression of cytopenia and dysplasia in one versus more than one lineage improves on the WHO classificationE Verburgh, R Achten, V J Louw, et al.
Annals of Hematology|August 6, 1998
Lymphocyte profiles in multiple myeloma and monoclonal gammopathy of undetermined significance: flow-cytometric characterization and analysis in a two-dimensional correlation biplotL E Van den Hove, P Meeus, A Derom, et al.
Nederlands Tijdschrift Voor Geneeskunde|September 27, 2006
[A man with FIP1L1/PDGFRA-positive chronic eosinophilic leukemia]O C Leeksma, G S de Ruiter, V P M van der Hulst, et al.
British Journal of Haematology|November 13, 2001
Can positron emission tomography with [(18)F]-fluorodeoxyglucose after first-line treatment distinguish Hodgkin's disease patients who need additional therapy from others in whom additional therapy would mean avoidable toxicity?K Spaepen, S Stroobants, P Dupont, et al.
Pageof 11

Showing results (61-70 of 108) with videos related to

Sort By:
Pageof 11
Frontiers in Neurology|May 9, 2024
Testing of symmetric biphasic stimulation in Vim-DBS ET patients: a randomized-controlled pilot studyAlexandra Boogers, Jana Peeters, Tine Van Bogaert, et al.
Research in Immunology|March 1, 1995
CD80 (B7-1) and CD86 (B7-2): potential targets for immunotherapy?S W van Gool, S Barcy, S Devos, et al.
British Journal of Haematology|February 1, 1996
Feasibility of peripheral blood progenitor cell harvest and transplantation in patients with poor-risk myelodysplastic syndromesH Demuynck, M Delforge, G E Verhoef, et al.
Journal of Clinical Microbiology|September 17, 1999
Autopsy-controlled prospective evaluation of serial screening for circulating galactomannan by a sandwich enzyme-linked immunosorbent assay for hematological patients at risk for invasive AspergillosisJ Maertens, J Verhaegen, H Demuynck, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 19, 2016
EBV-Positive and EBV-Negative Posttransplant Diffuse Large B Cell Lymphomas Have Distinct Genomic and Transcriptomic FeaturesJ Finalet Ferreiro, J Morscio, D Dierickx, et al.
Cancer Genetics and Cytogenetics|July 15, 1995
Therapy-related acute myeloid leukemia with t(8;16)(p11;p13) following anthracycline-based therapy for nonmetastatic osteosarcomaH Demuynck, G E Verhoef, P Zachée, et al.
Leukemia|February 16, 2007
A new disease categorization of low-grade myelodysplastic syndromes based on the expression of cytopenia and dysplasia in one versus more than one lineage improves on the WHO classificationE Verburgh, R Achten, V J Louw, et al.
Annals of Hematology|August 6, 1998
Lymphocyte profiles in multiple myeloma and monoclonal gammopathy of undetermined significance: flow-cytometric characterization and analysis in a two-dimensional correlation biplotL E Van den Hove, P Meeus, A Derom, et al.
Nederlands Tijdschrift Voor Geneeskunde|September 27, 2006
[A man with FIP1L1/PDGFRA-positive chronic eosinophilic leukemia]O C Leeksma, G S de Ruiter, V P M van der Hulst, et al.
British Journal of Haematology|November 13, 2001
Can positron emission tomography with [(18)F]-fluorodeoxyglucose after first-line treatment distinguish Hodgkin's disease patients who need additional therapy from others in whom additional therapy would mean avoidable toxicity?K Spaepen, S Stroobants, P Dupont, et al.
Pageof 11